Big pharma on a buying spree as Celgene buys Juno and Sanofi buys Bioverativ

9:08 AM ET Mon, 22 Jan 2018

The "Squawk on the Street" crew discusses Celgene's $9 billion cash deal for Juno Therapeutics and Sanofi's $11.6 billion bid for Massachusetts-based Bioverativ.